ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

No dose adjustment is required in elderly patients. There are limited data available on the use of cabotegravir in patients aged 65 years and over (see section 5.2). Renal impairment . No dosage adjustment is required in patients with mild to severe renal impairment (CrCl <30 mL/min

  Dose, Adjustment, Dose adjustment